The 2021 AMR Benchmark examines what 17 pharmaceutical companies are doing to help bring antimicrobial resistance under control. Here you can find the three key findings from 2021, as well in-depth analysis of the data and examples of best practice.

28 Results

Filter Results

28 FindingsResults Clear selected filters
All companies selected
All topics selected
All regions selected
All pathogens selected
See results

Get in touch

Back to top |